Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- cabotegravir
- lopinavir / ritonavir
Interactions between your drugs
ritonavir cabotegravir
Applies to: lopinavir / ritonavir, cabotegravir
Using ritonavir together with cabotegravir is not recommended. Combining these medications may significantly reduce the blood levels of cabotegravir, which may make it less effective in treating HIV infection. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
ritonavir food/lifestyle
Applies to: lopinavir / ritonavir
Ritonavir should be taken with food to lessen gastrointestinal side effects. It is important that you take this medication exactly as prescribed by your doctor. Do not change your treatment or stop treatment without first talking to your doctor.
lopinavir food/lifestyle
Applies to: lopinavir / ritonavir
Food may affect the absorption of lopinavir-ritonavir (brand name Kaletra) depending on whether you are taking the oral solution or the tablet. The oral solution should be taken with food to enhance absorption and help it work better. The tablet formulation can be take with or without food. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Apretude
Apretude is used to prevent HIV (HIV PrEP) in adults and adolescents weighing at least 77 pounds ...
Sunlenca
Sunlenca (lenacapavir) is used for the treatment of HIV-1 infection in heavily ...
Yeztugo
Yeztugo is used for HIV-1 PrEP to reduce the risk of getting HIV-1 in adults and adolescents who ...
Vocabria
Vocabria (cabotegravir) is used in the treatment of HIV-1 infection in adults. Includes Vocabria ...
AccessPak for HIV PEP Basic
AccessPak for HIV PEP Basic is used for HIV Infection, nonoccupational exposure, occupational ...
Lenacapavir
Lenacapavir is used to treat HIV-1 infection (in combination with other antivirals) or for HIV-1 ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.